DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
DANICAMTIV
1
Small molecule
Investigational
Unknown
Unknown
Cardiomyopathy, Dilated
Cardiac myosin activator
DANICAMTIV
×
Maximum Phase:
1
First Approval:
None
UNII:
7B2CS922HI
Molecule Type:
Small molecule
Molecular Formula:
C16H20F3N5O4S
Molecular Weight:
435.43
AlogP:
2.75
PSA:
110.33
HBD:
1.0
HBA:
#RotB:
5.0
Source:
RIMEPORIDE
1
Small molecule
Investigational
Unknown
Unknown
Muscular Dystrophy, Duchenne
Unknown
RIMEPORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
QH6B4V5743
Molecule Type:
Small molecule
Molecular Formula:
C11H15N3O5S2
Molecular Weight:
333.39
AlogP:
-0.57
PSA:
147.25
HBD:
3.0
HBA:
#RotB:
3.0
Source:
SD-0006
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
SD-0006
×
Maximum Phase:
1
First Approval:
None
UNII:
C57VF8YO91
Molecule Type:
Small molecule
Molecular Formula:
C20H20ClN5O2
Molecular Weight:
397.87
AlogP:
2.89
PSA:
95.0
HBD:
2.0
HBA:
#RotB:
4.0
Source:
LAS190792
1
Small molecule
Investigational
Unknown
Unknown
Asthma; Pulmonary Disease, Chronic Obstructive
Beta-2 adrenergic receptor agonist
LAS190792
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BETA ALETHINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BETA ALETHINE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMG-548
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
AMG-548
×
Maximum Phase:
1
First Approval:
None
UNII:
PGR0H531I4
Molecule Type:
Small molecule
Molecular Formula:
C29H27N5O
Molecular Weight:
461.57
AlogP:
4.64
PSA:
85.83
HBD:
2.0
HBA:
#RotB:
7.0
Source:
D6-25-HYDROXYVITAMIN D3
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
D6-25-HYDROXYVITAMIN D3
×
Maximum Phase:
1
First Approval:
None
UNII:
378HY809HV
Molecule Type:
Small molecule
Molecular Formula:
C27H44O2
Molecular Weight:
406.68
AlogP:
6.73
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
6.0
Source:
OBP-801
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
OBP-801
×
Maximum Phase:
1
First Approval:
None
UNII:
30Q3VS5HZ4
Molecule Type:
Small molecule
Molecular Formula:
C20H31N3O6S2
Molecular Weight:
473.62
AlogP:
0.52
PSA:
133.83
HBD:
4.0
HBA:
#RotB:
1.0
Source:
PERTECHNETATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PERTECHNETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
HO4Tc
Molecular Weight:
163.0
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CI-988
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cholecystokinin B receptor antagonist
CI-988
×
Maximum Phase:
1
First Approval:
None
UNII:
2637PDX9SI
Molecule Type:
Small molecule
Molecular Formula:
C35H42N4O6
Molecular Weight:
614.74
AlogP:
4.86
PSA:
149.62
HBD:
5.0
HBA:
#RotB:
12.0
Source:
TAK-441
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Basal Cell
Smoothened homolog antagonist
TAK-441
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C28H31F3N4O6
Molecular Weight:
576.57
AlogP:
2.44
PSA:
122.87
HBD:
2.0
HBA:
#RotB:
9.0
Source:
MK-8245
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
MK-8245
×
Maximum Phase:
1
First Approval:
None
UNII:
537E7QE8LX
Molecule Type:
Small molecule
Molecular Formula:
C17H16BrFN6O4
Molecular Weight:
467.26
AlogP:
2.36
PSA:
119.4
HBD:
1.0
HBA:
#RotB:
6.0
Source:
AZD-7451
1
Small molecule
Investigational
Unknown
Unknown
Glioblastoma
Nerve growth factor receptor Trk-A inhibitor
AZD-7451
×
Maximum Phase:
1
First Approval:
None
UNII:
VNM956Y27V
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MUSCIMOL
1
Small molecule
Investigational
Unknown
Unknown
Epilepsy; Parkinson Disease
Unknown
MUSCIMOL
×
Maximum Phase:
1
First Approval:
None
UNII:
D5M179TY2E
Molecule Type:
Small molecule
Molecular Formula:
C4H6N2O2
Molecular Weight:
114.1
AlogP:
-0.16
PSA:
72.28
HBD:
2.0
HBA:
#RotB:
1.0
Source:
GS-6620
1
Small molecule
Investigational
Unknown
Unknown
Hepatitis C, Chronic
Unknown
GS-6620
×
Maximum Phase:
1
First Approval:
None
UNII:
WD5DUG7X38
Molecule Type:
Small molecule
Molecular Formula:
C29H37N6O9P
Molecular Weight:
644.62
AlogP:
2.88
PSA:
209.62
HBD:
3.0
HBA:
#RotB:
12.0
Source:
ABT-107
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
ABT-107
×
Maximum Phase:
1
First Approval:
None
UNII:
SXS38HR98H
Molecule Type:
Small molecule
Molecular Formula:
C19H20N4O
Molecular Weight:
320.4
AlogP:
3.1
PSA:
54.04
HBD:
1.0
HBA:
#RotB:
3.0
Source:
BMS-791826
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-791826
×
Maximum Phase:
1
First Approval:
None
UNII:
60BN6CDL0K
Molecule Type:
Small molecule
Molecular Formula:
C28H26FN5O3S
Molecular Weight:
531.61
AlogP:
5.73
PSA:
97.31
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ROLUPERIDONE HYDROCHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Unknown
ROLUPERIDONE HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
WFL7TF8DTP
Molecule Type:
Small molecule
Molecular Formula:
C22H28ClFN2O4
Molecular Weight:
438.93
AlogP:
3.38
PSA:
40.62
HBD:
0.0
HBA:
#RotB:
5.0
Source:
RODATRISTAT ETHYL
1
Small molecule
Investigational
Unknown
Unknown
Hypertension, Pulmonary
Tryptophan 5-hydroxylase 1 inhibitor
RODATRISTAT ETHYL
×
Maximum Phase:
1
First Approval:
None
UNII:
507FY6OL37
Molecule Type:
Small molecule
Molecular Formula:
C29H31ClF3N5O3
Molecular Weight:
590.05
AlogP:
5.57
PSA:
102.6
HBD:
2.0
HBA:
#RotB:
7.0
Source:
BRICICLIB SODIUM
1
Small molecule
Investigational
Unknown
Unknown
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Unknown
BRICICLIB SODIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
7C9N0VM8NR
Molecule Type:
Small molecule
Molecular Formula:
C19H21Na2O10PS
Molecular Weight:
518.39
AlogP:
2.78
PSA:
137.82
HBD:
2.0
HBA:
#RotB:
10.0
Source:
TALADEGIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasm Metastasis; Neoplasms; Small Cell Lung Carcinoma; Idiopathic Pulmonary Fibrosis
Smoothened homolog antagonist
TALADEGIB
×
Maximum Phase:
1
First Approval:
None
UNII:
QY8BWX1LJ5
Molecule Type:
Small molecule
Molecular Formula:
C26H24F4N6O
Molecular Weight:
512.51
AlogP:
4.93
PSA:
67.15
HBD:
0.0
HBA:
#RotB:
4.0
Source:
BISTHIANOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
BISTHIANOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O3S2
Molecular Weight:
366.47
AlogP:
2.55
PSA:
104.21
HBD:
3.0
HBA:
#RotB:
8.0
Source:
BMS-986166
1
Small molecule
Investigational
Unknown
Unknown
Colitis, Ulcerative
Unknown
BMS-986166
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C25H33NO2
Molecular Weight:
379.54
AlogP:
4.39
PSA:
55.48
HBD:
2.0
HBA:
#RotB:
6.0
Source:
PFK-158
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
PFK-158
×
Maximum Phase:
1
First Approval:
None
UNII:
2HOK1JQ203
Molecule Type:
Small molecule
Molecular Formula:
C18H11F3N2O
Molecular Weight:
328.29
AlogP:
4.54
PSA:
42.85
HBD:
0.0
HBA:
#RotB:
3.0
Source:
CFG-920
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
CFG-920
×
Maximum Phase:
1
First Approval:
None
UNII:
UP0K5026VB
Molecule Type:
Small molecule
Molecular Formula:
C14H13ClN4O
Molecular Weight:
288.74
AlogP:
2.89
PSA:
49.33
HBD:
0.0
HBA:
#RotB:
2.0
Source:
BI113823
1
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis
Bradykinin B1 receptor antagonist
BI113823
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AG-24322
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin
Cyclin-dependent kinase 1 inhibitor
AG-24322
×
Maximum Phase:
1
First Approval:
None
UNII:
926F8X7TNO
Molecule Type:
Small molecule
Molecular Formula:
C23H20F2N6
Molecular Weight:
418.45
AlogP:
2.95
PSA:
73.7
HBD:
3.0
HBA:
#RotB:
4.0
Source:
TIGULIXOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TIGULIXOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
WZ0PYQ6VLU
Molecule Type:
Small molecule
Molecular Formula:
C16H14N4O2
Molecular Weight:
294.31
AlogP:
2.98
PSA:
83.84
HBD:
1.0
HBA:
#RotB:
3.0
Source:
FK453
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Adenosine A1 receptor antagonist
FK453
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C23H25N3O2
Molecular Weight:
375.47
AlogP:
3.78
PSA:
57.84
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CH5132799
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CH5132799
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIINDOLYLMETHANE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DIINDOLYLMETHANE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FUSILEV
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FUSILEV
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MURAMYL DIPEPTIDE
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
MURAMYL DIPEPTIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
2U7S2HVO96
Molecule Type:
Small molecule
Molecular Formula:
C19H32N4O11
Molecular Weight:
492.48
AlogP:
-4.33
PSA:
246.84
HBD:
8.0
HBA:
#RotB:
12.0
Source:
BMS-794833
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Hepatocyte growth factor receptor inhibitor
BMS-794833
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEVOSULPIRIDE
1
Small molecule
Investigational
Unknown
Unknown
Dyspepsia; Psychomotor Agitation; Psychotic Disorders
Dopamine D2 receptor antagonist
LEVOSULPIRIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
JTG7R315LK
Molecule Type:
Small molecule
Molecular Formula:
C15H23N3O4S
Molecular Weight:
341.43
AlogP:
0.56
PSA:
101.73
HBD:
2.0
HBA:
#RotB:
6.0
Source:
1
2
…
72
73
74
75
76
77
78
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA